CVACCureVac N.V.

CVAC Stock Price, Valuation & Chart | CureVac N.V.

Compare

$4.660+0.00 (+0.00%)

At close · 06 Jan 2026, 09:00 pm

Sector: Healthcare Industry: Biotechnology CVAC intrinsic value CVAC calculated fair value vs price

Overview Financials Dividends Ratios

CVAC Historical price chart

CVAC Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.05B

PE Ratio6.96

EPS0.67

Trading Volume728.78K

Today's High/Low4.66/4.57

Dividend Yield0.00

52 Week High/Low5.72/2.48

Shares Outstanding225.17M

CVAC Financial Statement

CVAC Analyst ratings

CVAC Analysis & performance metrics

CVAC Company profile

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing…

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for…

CVAC Management team

Name

Position

Thaminda Ramanayake

Chief Business Officer & Member of Executive Board

Patrick Baumhof

Senior Vice President of Technology

Marco Rau L.L.M., Ph.D.

General Counsel

Sarah Fakih

Vice President Corporate Communications & Investor Relations

Alexander Zehnder M.B.A., M.D.CEO

Chief Executive Officer, MD & Member of Management Board

Axel-Sven MalkomesCFO

Chief Financial Officer & Member of Executive Board

Malte Greune Ph.D.COO

Chief Operating Officer, Member of Management Board & MD

Myriam Mendila M.D.

Chief Scientific Officer, Head of R&D, MD & Member of the Management Board

Name

Position

Thaminda Ramanayake

Chief Business Officer & Member of Executive Board

Patrick Baumhof

Senior Vice President of Technology

Marco Rau L.L.M., Ph.D.

General Counsel

Sarah Fakih

Vice President Corporate Communications & Investor Relations

Alexander Zehnder M.B.A., M.D.CEO

Chief Executive Officer, MD & Member of Management Board

Axel-Sven MalkomesCFO

Chief Financial Officer & Member of Executive Board

Malte Greune Ph.D.COO

Chief Operating Officer, Member of Management Board & MD

Myriam Mendila M.D.

Chief Scientific Officer, Head of R&D, MD & Member of the Management Board

Management Team

Thaminda Ramanayake

Chief Business Officer & Member of Executive Board

Patrick Baumhof

Senior Vice President of Technology

Marco Rau L.L.M., Ph.D.

General Counsel

Sarah Fakih

Vice President Corporate Communications & Investor Relations

Alexander Zehnder M.B.A., M.D.CEO

Chief Executive Officer, MD & Member of Management Board

Axel-Sven MalkomesCFO

Chief Financial Officer & Member of Executive Board

Malte Greune Ph.D.COO

Chief Operating Officer, Member of Management Board & MD

Myriam Mendila M.D.

Chief Scientific Officer, Head of R&D, MD & Member of the Management Board

Management

Thaminda Ramanayake

Chief Business Officer & Member of Executive Board

Patrick Baumhof

Senior Vice President of Technology

Marco Rau L.L.M., Ph.D.

General Counsel

Sarah Fakih

Vice President Corporate Communications & Investor Relations

Alexander Zehnder M.B.A., M.D.CEO

Chief Executive Officer, MD & Member of Management Board

Axel-Sven MalkomesCFO

Chief Financial Officer & Member of Executive Board

Malte Greune Ph.D.COO

Chief Operating Officer, Member of Management Board & MD

Myriam Mendila M.D.

Chief Scientific Officer, Head of R&D, MD & Member of the Management Board

Total 8 executives

CVAC Frequently asked questions

What is CureVac N.V. (CVAC) Stock Price?

Current stock price of CureVac N.V. (CVAC) stock is $4.660. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of CureVac N.V. (CVAC) stock is 728.78K.

Last updated at 06 Jan 2026, 09:00 pm.

Why is the CureVac N.V. (CVAC) stock price going up or down today?

The stock price of CureVac N.V. (CVAC) can change with earnings, company news, and overall market sentiment. CureVac N.V. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CureVac N.V. stock expensive at its current price?

Whether CureVac N.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CVAC on this page is 6.96. EPS on this page is 0.67. Compare those figures with peers and growth expectations before deciding if the current CureVac N.V. price is justified.

How has the stock price of CureVac N.V. (CVAC) performed historically?

Historical performance for CureVac N.V. (CVAC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CVAC reacted to past earnings and market events.

Should I buy CureVac N.V. (CVAC) stock, at this price?

Buying CureVac N.V. (CVAC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.